While zinc concentration may exceed 10 μM under lots of pathologic conditions, such as during ischemia, or in zinc-accumulated senile plaques in AD, it is reasonable to speculate a direct inhibitory effect of zinc on PP-2A exists in the development of brain disorders, such as stroke and AD. This evidence concerns the gene PTPA and Alzheimer disease.